EUVIMEDEUVIMED entdecken
Open Access

PD-1 regulates tumor-infiltrating CD8+ T cells in both a cell-intrinsic and a cell-extrinsic fashion

Kristen E Pauken iD, Samuel C Markson iD, Thomas S Conway iD, Vikram R Juneja iD, Osmaan Shahid iD, Kelly P Burke iD, Jared H Rowe iD, Thao H Nguyen iD, Jenna L Collier iD, Jaclyn M L Walsh iD, Megan E Fung iD, Jacob M Luber iD und 6 weitere

Journal of Experimental Medicine · 06.10.2025 · 222 (10)

DOI: 10.1084/jem.20230542 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Experimental Medicine, online erschienen am 24.07.2025. Verfasst von Kristen E Pauken und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Programmed Cell Death 1 Receptor, CD8-Positive T-Lymphocytes, Lymphocytes, Tumor-Infiltrating. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NCATS NIH HHS, Cancer Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although PD-1 inhibitors are FDA-approved for over 25 different cancers, the mechanisms contributing to response remain incompletely understood. To investigate how PD-1–deleted CD8+ T cells influence PD-1–expressing CD8+ T cells in the same tumor microenvironment, we developed an inducible PD-1 knockout (KO) model in which PD-1 is deleted on ∼50% of cells. PD-1 deletion beginning at day 7 after implantation of MC38 tumor cells led to robust tumor control. Remarkably, PD-1–expressing CD8+ T cells in the tumor had increased functionality similar to PD-1 KO CD8+ T cells. Using single-cell RNA-seq and TCR-seq, we found that the major transcriptional changes following PD-1 deletion were shared by PD-1 KO and PD-1–expressing CD8+ T cells, although PD-1 KO clones preferentially expanded. These data suggest PD-1 inhibitors not only exert cell-intrinsic effects but also may promote increased T cell function through non–cell-autonomous mechanisms, which has important implications for design of PD-1–based cancer immunotherapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Programmed Cell Death 1 ReceptorCD8-Positive T-LymphocytesLymphocytes, Tumor-InfiltratingAnimalsMiceMice, KnockoutTumor MicroenvironmentMice, Inbred C57BLCell Line, TumorNeoplasms

Substanzen

Programmed Cell Death 1 ReceptorPdcd1 protein, mouse

Autor:innen und Institutionen

  • Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
  • Gene Lay Institute of Immunology and Inflammation, Brigham and Women's Hospital, Massachusetts General Hospital and Harvard Medical School , Boston, MA, USA.
  • Broad Institute of MIT and Harvard , Cambridge, MA, USA.
  • Harvard-MIT Division of Health Sciences and Technology , Cambridge, MA, USA.
  • Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.

ORCID-Profile: Kristen E Pauken, Samuel C Markson, Thomas S Conway, Vikram R Juneja, Osmaan Shahid, Kelly P Burke, Jared H Rowe, Thao H Nguyen, Jenna L Collier, Jaclyn M L Walsh, Megan E Fung, Jacob M Luber, Alison E Ringel, Jason M Schenkel, Gordon J Freeman, Marcia C Haigis, Meromit Singer, Arlene H Sharpe

Förderung

  • NIH HHS
  • NCATS NIH HHS
  • Cancer Research Institute
  • Gene Lay Institute of Immunology and Inflammation
  • Cancer Prevention and Research Institute of Texas
  • Andrew Sabin Family Foundation
  • NIAID NIH HHS
  • American Association of Immunologists Intersect

Zitieren

APA

Pauken, K. E., Markson, S. C., Conway, T. S., Juneja, V. R., Shahid, O., Burke, K. P., Rowe, J. H., Nguyen, T. H., Collier, J. L., Walsh, J. M. L., Fung, M. E., Luber, J. M., Ringel, A. E., Schenkel, J. M., Freeman, G. J., Haigis, M. C., Singer, M., & Sharpe, A. H. (2025). PD-1 regulates tumor-infiltrating CD8+ T cells in both a cell-intrinsic and a cell-extrinsic fashion. Journal of Experimental Medicine, 222(10). https://doi.org/10.1084/jem.20230542

Vancouver

Pauken KE, Markson SC, Conway TS, Juneja VR, Shahid O, Burke KP, et al. PD-1 regulates tumor-infiltrating CD8+ T cells in both a cell-intrinsic and a cell-extrinsic fashion. Journal of Experimental Medicine. 2025;222(10). doi:10.1084/jem.20230542

BibTeX
@article{Pauken2025,
  author = {Pauken, Kristen E and Markson, Samuel C and Conway, Thomas S and Juneja, Vikram R and Shahid, Osmaan and Burke, Kelly P and Rowe, Jared H and Nguyen, Thao H and Collier, Jenna L and Walsh, Jaclyn M L and Fung, Megan E and Luber, Jacob M and Ringel, Alison E and Schenkel, Jason M and Freeman, Gordon J and Haigis, Marcia C and Singer, Meromit and Sharpe, Arlene H},
  title = {PD-1 regulates tumor-infiltrating CD8+ T cells in both a cell-intrinsic and a cell-extrinsic fashion},
  journal = {Journal of Experimental Medicine},
  year = {2025},
  volume = {222},
  number = {10},
  doi = {10.1084/jem.20230542}
}
Kostenlos starten →